Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An established industry player is seeking a Senior Clinical Scientist to lead clinical trials in oncology and haematology. This role involves managing a diverse research portfolio, advocating for patients, and ensuring compliance with clinical guidelines. You'll collaborate with a dedicated team to deliver top-notch patient care and contribute to groundbreaking research. Join a forward-thinking organization committed to sustainability and excellence in healthcare, making a real difference in patients' lives while advancing your career in a supportive environment.
Client: University College London Hospitals
Location: London, United Kingdom
Job Category: Other
EU work permit required: Yes
Job Reference: 56640127e68c
Job Views: 6
Posted: 05.05.2025
Expiry Date: 19.06.2025
Job overview
The Research Nurse/Clinical Trials Practitioner is an autonomous specialist working within a multi-disciplinary team. The post holder will coordinate and manage a clinical research portfolio including in-house, national, and international phase I, II, and III clinical trials. Positions are available in cellular therapies and paediatric/TYA oncology and haematology.
Responsibilities include patient and colleague education, care coordination for trial participants, biological sample collection and preparation, data collection, and monitoring drug and treatment side effects.
The post requires developing specialized skills in clinical trials, therapies, and disease sites, enabling patients to make informed decisions about participation by providing advice and acting as their advocate.
The role supports research across all oncology and haematological malignancies and includes cross-coverage within the team.
University College London Hospitals NHS Foundation Trust (UCLH) is a leading NHS trust serving a diverse population with complex health needs. We provide top-quality patient care, education, and research across eight sites, including specialized services in neurology, cancer, and more. Our commitment to sustainability aims for net zero carbon emissions by 2031 (direct) and 2040 (indirect).